ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Citius Pharmaceuticals (CTXR) Technical (Analysis) Reports Citius Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Citius Pharmaceuticals (CTXR)

Technical Analysis Report for USA stock CTXR Citius Pharmaceuticals. Dated: 12 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock CTXR Citius Pharmaceuticals then click here. or read Experts views on Citius Pharmaceuticals or Forecast & share price targets of Citius Pharmaceuticals

Citius Pharmaceuticals Opened at 1.15 and Closed at: 1.12, which is -3.57% of previous session's close. It moved within a range of 1.11 and 1.20
The session was a Bearish session with an average volume of 194900, which is -49.2% of previous session's volumes.

    A Golden cross was found 9 days back on short term averages

    Support for tomorrow is 1.07 and resistance for tomorrow is 1.16
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 1.09, 1.05 resistance for tomorrow's hourly charts is 1.18, 1.23

    10 Day SMA for Citius Pharmaceuticals (CTXR) is 1.2 and stock is trading below these levels. This is not a good sign for its short term trend

    20 Day SMA for Citius Pharmaceuticals (CTXR) is 1.17 and the stock is trading below these levels. This is not a good sign for its mid term trend

    50 Day SMA for Citius Pharmaceuticals (CTXR) is 1.32 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

    100 Day SMA is 1.3 and the stock is trading below these levels. This is not a good sign for its long term trend

    200 Day SMA Citius Pharmaceuticals is 1.25 and stock is trading below these levels. This is not a good sign for its long term trend

    20 DMA of Citius Pharmaceuticals is at 1.17 and 200 DMA is at 1.25, while 50 DMA and 100 DMA are at 1.32 and 1.3 respectively

    Citius Pharmaceuticals (CTXR) moving average of 20 SMA is at 1.17 and 20 EMA is at 1.2

    Citius Pharmaceuticals (CTXR) moving average of 50 SMA is at 1.32 and 50 EMA is at 1.26

    Citius Pharmaceuticals (CTXR) moving average of 100 SMA is at 1.3 and 100 EMA is at 1.35

    Citius Pharmaceuticals (CTXR) moving average of 200 SMA is at 1.25 and 200 EMA is at 1.27

    Citius Pharmaceuticals has performed better than 3m Company in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Citius Pharmaceuticals has performed better than Xencor Inc in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Citius Pharmaceuticals has performed better than Vertex Pharmaceuticals in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Citius Pharmaceuticals has performed better than Viking Therapeutics in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Regenxbio Inc has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Regenxbio Inc, about 6.21% more returns!

    Citius Pharmaceuticals has performed better than Redhill Biopharma in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Citius Pharmaceuticals has performed better than Pulse Biosciences in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Citius Pharmaceuticals has performed better than Immuron in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Citius Pharmaceuticals has performed better than Grifols S in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Citius Pharmaceuticals has performed better than Fortress Biotech in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Fate Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Fate Therapeutics, about 5.5% more returns!

    Citius Pharmaceuticals has performed better than Catalyst Biosciences in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Citius Pharmaceuticals has performed better than Atossa Genetics in short term. Holding Citius Pharmaceuticals could be a better choice for now!

    Arrowhead Pharmaceuticals has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 55.58% more returns!

    Citius Pharmaceuticals Technical analysis of indicators

    Price action analysis of Citius Pharmaceuticals (CTXR) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

    ADX buy sell signal for Citius Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a SELL signal for Citius Pharmaceuticals in short term and the sell signal is strong.

    Citius Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

    Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

    CCI has generated a SELL signal for Citius Pharmaceuticals in short term and SELL signal is strong!

    RSI is generating a BUY signal in short term and the buying is gaining momentum.

    MRSI is in positive zone. This is a BUY zone

    Stock of Citius Pharmaceuticals is picking up buying momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 1.22 and Citius Pharmaceuticals CTXR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Citius Pharmaceuticals CTXR stock. Volume based technical analysis of Citius Pharmaceuticals CTXR stock is negative.

    Citius Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for USA stock CTXR Citius Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And CTXR Experts View which covers a lot of information including buying and selling signals

    CTXR future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Citius Pharmaceuticals or View Candle Stick Charts here

    Chart Citius Pharmaceuticals (CTXR)  Technical (Analysis) Reports Citius Pharmaceuticals [

    Videos related to: Citius Pharmaceuticals (CTXR) Technical (Analysis) Reports Citius Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

    Hindi Basics How To Trade In FnO Futures Options Stock Market

    Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

    Citius Pharmaceuticals (CTXR)  Technical (Analysis) Reports Citius Pharmaceuticals [

     

    Back to top